A Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
Compass Therapeutics
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Second Life Therapeutics
University of South Florida
Universidade Federal de Pernambuco
Danatlas Pharmaceuticals Co., Ltd
Fondazione Policlinico Universitario Agostino Gemelli IRCCS